Overview
- Description
Betalin Therapeutics is developing the next generation of insulin-producing cell transplantation providing a solution for insulin-dependent diabetic people using tissue engineering.
The company is currently raising capital to further optimize the therapy and complete submission of the New Drug (IND) application to the FDA and proceed to clinical trials.
- Website
- Invested amount
EUR 500 000
- Founded
2015
- Project
- Country
- Israel
- Theme
- Health